Sample size efficiency of restricting participation in tuberculosis vaccine trials to interferongamma release assaypositive participants
| dc.article.end-page | 8 | en |
| dc.article.start-page | 1 | en |
| dc.citation.doi | 10.1016/J.VACCINE.2025.127301 | en |
| dc.contributor.author | F Cobelens | en |
| dc.contributor.author | P Pelzer | en |
| dc.contributor.author | Gavin Churchyard | en |
| dc.contributor.author | A Garcia-Basteiro | en |
| dc.contributor.author | M Hatherill | en |
| dc.contributor.author | E et al | en |
| dc.date.accessioned | 2025-11-13T10:23:24Z | |
| dc.faculty | FACULTY OF HEALTH SCIENCES | en |
| dc.identifier.citation | WOS | en |
| dc.identifier.issn | 0264-410X | en |
| dc.identifier.uri | https://hdl.handle.net/10539/47623 | |
| dc.journal.title | Sample size efficiency of restricting participation in tuberculosis vaccine trials to interferongamma release assaypositive participants | en |
| dc.journal.volume | 61 | en |
| dc.title | Sample size efficiency of restricting participation in tuberculosis vaccine trials to interferongamma release assaypositive participants | en |
| dc.type | Journal Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Journal Article.pdf
- Size:
- 3.04 MB
- Format:
- Adobe Portable Document Format
- Description:
- Bitstream uploaded by REST Client